Bank of New York Mellon
VRTX icon

Bank of New York Mellon’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$713M Sell
1,600,473
-111,192
-6% -$49.5M 0.13% 145
2025
Q1
$830M Sell
1,711,665
-47,551
-3% -$23.1M 0.16% 121
2024
Q4
$708M Sell
1,759,216
-27,512
-2% -$11.1M 0.13% 144
2024
Q3
$831M Sell
1,786,728
-50,922
-3% -$23.7M 0.15% 125
2024
Q2
$861M Sell
1,837,650
-36,479
-2% -$17.1M 0.16% 115
2024
Q1
$783M Sell
1,874,129
-102,859
-5% -$43M 0.15% 131
2023
Q4
$804M Sell
1,976,988
-36,908
-2% -$15M 0.16% 126
2023
Q3
$700M Buy
2,013,896
+16,439
+0.8% +$5.72M 0.15% 128
2023
Q2
$703M Sell
1,997,457
-40,447
-2% -$14.2M 0.15% 127
2023
Q1
$642M Sell
2,037,904
-44,395
-2% -$14M 0.14% 138
2022
Q4
$601M Buy
2,082,299
+829
+0% +$239K 0.14% 151
2022
Q3
$603M Sell
2,081,470
-16,831
-0.8% -$4.87M 0.15% 138
2022
Q2
$591M Buy
2,098,301
+95,436
+5% +$26.9M 0.14% 146
2022
Q1
$523M Sell
2,002,865
-59,941
-3% -$15.6M 0.1% 179
2021
Q4
$453M Sell
2,062,806
-25,982
-1% -$5.71M 0.08% 211
2021
Q3
$379M Sell
2,088,788
-25,930
-1% -$4.7M 0.07% 233
2021
Q2
$426M Sell
2,114,718
-33,948
-2% -$6.84M 0.08% 212
2021
Q1
$462M Sell
2,148,666
-133,222
-6% -$28.6M 0.09% 192
2020
Q4
$539M Sell
2,281,888
-315,296
-12% -$74.5M 0.12% 152
2020
Q3
$707M Buy
2,597,184
+87,014
+3% +$23.7M 0.17% 108
2020
Q2
$729M Buy
2,510,170
+17,545
+0.7% +$5.09M 0.19% 100
2020
Q1
$593M Sell
2,492,625
-16,775
-0.7% -$3.99M 0.2% 105
2019
Q4
$549M Sell
2,509,400
-72,194
-3% -$15.8M 0.14% 137
2019
Q3
$437M Buy
2,581,594
+3,444
+0.1% +$583K 0.12% 164
2019
Q2
$473M Buy
2,578,150
+296,068
+13% +$54.3M 0.13% 151
2019
Q1
$420M Buy
2,282,082
+76,930
+3% +$14.2M 0.12% 159
2018
Q4
$365M Sell
2,205,152
-124,886
-5% -$20.7M 0.11% 164
2018
Q3
$449M Sell
2,330,038
-557
-0% -$107K 0.12% 167
2018
Q2
$396M Sell
2,330,595
-21,447
-0.9% -$3.65M 0.11% 179
2018
Q1
$383M Buy
2,352,042
+332,476
+16% +$54.2M 0.11% 191
2017
Q4
$303M Buy
2,019,566
+25,156
+1% +$3.77M 0.08% 252
2017
Q3
$303M Buy
1,994,410
+12,454
+0.6% +$1.89M 0.08% 247
2017
Q2
$255M Sell
1,981,956
-102,277
-5% -$13.2M 0.07% 276
2017
Q1
$228M Buy
2,084,233
+5,611
+0.3% +$614K 0.06% 324
2016
Q4
$153M Sell
2,078,622
-957,092
-32% -$70.5M 0.04% 420
2016
Q3
$265M Buy
3,035,714
+13,278
+0.4% +$1.16M 0.08% 269
2016
Q2
$260M Sell
3,022,436
-143,602
-5% -$12.4M 0.08% 263
2016
Q1
$252M Sell
3,166,038
-432,400
-12% -$34.4M 0.08% 270
2015
Q4
$453M Sell
3,598,438
-287,256
-7% -$36.1M 0.14% 156
2015
Q3
$405M Sell
3,885,694
-456,855
-11% -$47.6M 0.12% 167
2015
Q2
$536M Sell
4,342,549
-125,066
-3% -$15.4M 0.15% 140
2015
Q1
$527M Buy
4,467,615
+556,777
+14% +$65.7M 0.14% 155
2014
Q4
$465M Buy
3,910,838
+325,584
+9% +$38.7M 0.12% 178
2014
Q3
$403M Buy
3,585,254
+259,581
+8% +$29.2M 0.11% 192
2014
Q2
$315M Buy
3,325,673
+424,403
+15% +$40.2M 0.08% 252
2014
Q1
$205M Buy
2,901,270
+101,001
+4% +$7.14M 0.06% 349
2013
Q4
$208M Sell
2,800,269
-95,399
-3% -$7.09M 0.06% 334
2013
Q3
$220M Buy
2,895,668
+223,252
+8% +$16.9M 0.07% 313
2013
Q2
$214M Buy
+2,672,416
New +$214M 0.07% 306